SCHEMBL6137934

SCHEMBL6137934

N=C(N)N(CCCCc1ccccc1)C(=O)c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 1/20 0.49
SCN2A Q99250 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.44
TMEM97 Q5BJF2 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
AGER Q15109 1/20 0.43
PTGIR P43119 1/20 0.43
MAPT P10636 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CNR1 P21554 2/20 0.41
PLAAT3 P53816 1/20 0.41
PLAAT5 Q96KN8 1/20 0.41
PLAAT2 Q9NWW9 1/20 0.41
PLAAT4 Q9UL19 1/20 0.41
CNR2 P34972 1/20 0.41
ADAMTS4 O75173 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
C5AR1 P21730 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137843 0.91 TDP1 (0.45) SIGMAR1MAPTKMT2AF2F10
SCHEMBL6003647 0.84 LPAR1 (0.53) SCN5ASCN2AL3MBTL1HTTMAPT
SCHEMBL6137977 0.82 AGER (0.54) L3MBTL1HTTTMEM97SIGMAR1AGER
SCHEMBL6137825 0.77 HPGD (0.50) SCN5ASCN2AL3MBTL1SIGMAR1KMT2A
SCHEMBL6137987 0.76 L3MBTL1 (0.48) L3MBTL1HTTAGERMAPTMEN1
SCHEMBL6137874 0.76 F2 (0.54) SCN5ASCN2AL3MBTL1CNR1CNR2
SCHEMBL8582839 0.75 HPGD (0.44) NPC1RAB9A
SCHEMBL6137989 0.75 AGER (0.42) L3MBTL1HTTAGERMAPTMEN1
SCHEMBL6137813 0.74 TP53 (0.46) PTGIRMAPT
SCHEMBL6138071 0.74 MAPT (0.47) SCN5ASCN2AL3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed